Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 8/2016

01-08-2016 | Original paper

Receipt of mammography recommendations among White and non-White women before and after the 2009 United States Preventive Services Task Force recommendation change

Authors: Felisa A. Gonzales, Stephen H. Taplin, Mandi Yu, Nancy Breen, Kathy A. Cronin

Published in: Cancer Causes & Control | Issue 8/2016

Login to get access

Abstract

Purpose

Receipt of a mammography recommendation from a physician is a strong predictor of obtaining a mammogram. In 2009, the United States Preventive Services Task Force (USPSTF) recommended routine biennial mammography for women aged 50–74 but not for women aged 40–49. We examined changes in reports of clinician recommendations for mammography among White and non-White women after these age-specific recommendations were issued.

Methods

Data from women aged 40–49 and 50–74 were drawn from the 2008 and 2013 National Health Interview Surveys. We used linear probability models to determine whether the proportions of women reporting a mammography recommendation changed after the USPSTF recommendation was issued and whether any changes observed differed across White and non-White women. All analyses were stratified by age groups and mammography history.

Results

Among women without a recent mammogram, reported clinician recommendations did not change for White women, but they decreased by 13-percentage points (95 % CI −0.22, −0.03) among non-White women aged 40–49 (p = 0.01) and increased by 9-percentage points (95 % CI 0.01, 0.17) among non-White women aged 50–74 (p = 0.04). Among women with a mammogram in the past 2 years, reported mammography recommendation from a clinician did not change for White or non-White women.

Conclusions

Recommendations to reduce screening may be differentially implemented across racial/ethnic groups. Changes in reports of mammography recommendation from a clinician after the USPSTF breast cancer screening recommendation change were observed only among non-White women without a recent history of mammography. It is unclear whether these differences are due to the clinician, the women, or both.
Appendix
Available only for authorised users
Literature
1.
American Cancer Society (2015) Breast cancer facts and figures: 2015–2016. American Cancer Society, Atlanta
2.
Wheeler SB, Reeder-Hayes KE, Carey LA (2013) Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research. Oncologist 18(9):986–993CrossRefPubMedPubMedCentral
3.
4.
Braveman P (2014) What are health disparities and health equity? We need to be clear. Public Health Rep 129(Suppl 2):5–8PubMedPubMedCentral
5.
Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A et al (2004) Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 54(2):78–93CrossRefPubMed
6.
Committee on Assuring the Health of the Public in the 21st Century (2003) The future of the public’s health in the 21st century. The National Academies Press, Washington, DC
7.
Bretthauer M, Kalager M (2013) Principles, effectiveness and caveats in screening for cancer. Br J Surg 100(1):55–65CrossRefPubMed
8.
Schueler KM, Chu PW, Smith-Bindman R (2008) Factors associated with mammography utilization: a systematic quantitative review of the literature. J Womens Health (Larchmt) 17(9):1477–1498CrossRef
9.
U.S. Preventive Services Task Force (2009) Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 151(10):716–726, W-236
10.
Siu AL (2016) Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 164(4):279–296
11.
Block LD, Jarlenski MP, Wu AW, Bennett WL (2013) Mammography use among women ages 40–49 after the 2009 U.S. Preventive Services Task Force recommendation. J Gen Intern Med 28(11):1447–1453CrossRefPubMedPubMedCentral
12.
Dehkordy SF, Hall KS, Roach AL, Rothman ED, Dalton VK, Carlos RC (2015) Trends in Breast Cancer Screening: Impact of U.S. Preventive Services Task Force Recommendations. Am J Prev Med 49(3):419–422CrossRefPubMed
13.
Howard DH, Adams EK (2012) Mammography rates after the 2009 US Preventive Services Task Force breast cancer screening recommendation. Prev Med 55(5):485–487CrossRefPubMed
14.
Pace LE, He Y, Keating NL (2013) Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer 119(14):2518–2523CrossRefPubMed
15.
Sprague BL, Bolton KC, Mace JL, Herschorn SD, James TA, Vacek PM et al (2014) Registry-based study of trends in breast cancer screening mammography before and after the 2009 U.S. Preventive Services Task Force recommendations. Radiology 270(2):354–361CrossRefPubMedPubMedCentral
16.
Wang AT, Fan J, Van Houten HK, Tilburt JC, Stout NK, Montori VM et al (2014) Impact of the 2009 US Preventive Services Task Force guidelines on screening mammography rates on women in their 40s. PLoS One 9(3):e91399CrossRefPubMedPubMedCentral
17.
Wharam JF, Landon B, Zhang F, Xu X, Soumerai S, Ross-Degnan D (2015) Mammography rates 3 years after the 2009 US Preventive Services Task Force Guidelines changes. J Clin Oncol 33(9):1067–1074CrossRefPubMed
18.
19.
Fedewa SA, de Moor JS, Ward EM, DeSantis CE, Goding Sauer A, Smith RA, Jemal A (2016) Mammography use and physician recommendation after the 2009 U.S. Preventive Services Task Force breast cancer screening recommendations. Am J Prev Med 50(5):e123–e131
20.
Institute of Medicine (2003) Unequal treatment: confronting racial and ethnic disparities in health care. In: Smedley BD, Stith AY, Nelson AR (eds) National Academies Press, Washington DC
21.
Frohlich KL, Potvin L (2008) Transcending the known in public health practice: the inequality paradox: the population approach and vulnerable populations. Am J Public Health 98(2):216–221CrossRefPubMedPubMedCentral
22.
Phelan JC, Link BG (2005) Controlling disease and creating disparities: a fundamental cause perspective. J Gerontol B Psychol Sci Soc Sci 60(2):27–33CrossRefPubMed
23.
Phelan JC, Link BG, Tehranifar P (2010) Social conditions as fundamental causes of health inequalities: theory, evidence, and policy implications. J Health Soc Behav 51(Suppl):S28–S40CrossRefPubMed
24.
Tehranifar P, Neugut AI, Phelan JC, Link BG, Liao Y, Desai M et al (2009) Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev 18(10):2701–2708PubMedPubMedCentral
25.
26.
Division of Health Interview Statistics, National Center for Health Statistics (2009) National Health Interview Survey (NHIS) public use data release: 2008 survey description. Centers for Disease Control and Prevention, US Department of Health and Human Services
27.
Division of Health Interview Statistics, National Center for Health Statistics (2014) National Health Interview Survey (NHIS) public use data release: 2013 survey description. Centers for Disease Control and Prevention, US Department of Health and Human Services
28.
Parsons V, Moriarity C, Jonas K, Moore T, Davis K, Tompkins L (2014) Design and estimation for the National Health Interview Survey, 2006–2015. Vital Health Stat 2(165):1–53
29.
Sabatino SA, White MC, Thompson TD, Klabunde CN (2015) Cancer screening test use—United States, 2013. Mortal Morb Wkly Rep 64(17):464–468
30.
Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman ME (2008) An overview of methods for monitoring social disparities in cancer with an example using trends in lung cancer incidence by area-socioeconomic position and race-ethnicity, 1992–2004. Am J Epidemiol 167(8):889–899CrossRefPubMedPubMedCentral
31.
32.
Raghunathan T, Lepkowski J, Hoewyk JV, Solenberger P (2001) A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol 27(1):85–95
33.
Rubin D (1987) Multiple imputation for nonresponse in surveys. Wiley, New YorkCrossRef
34.
Meng X (1994) Multiple-imputation inferences with uncongenial sources of input. Stat Sci 9(4):538–573
35.
Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L (2009) Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 151(10):727–737, W237-42
36.
Ooi SL, Martinez ME, Li CI (2011) Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat 127(3):729–738CrossRefPubMed
37.
Danforth DN Jr (2013) Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors. Breast Cancer Res 15(3):208CrossRefPubMedPubMedCentral
38.
Campbell RT, Li X, Dolecek TA, Barrett RE, Weaver KE, Warnecke RB (2009) Economic, racial and ethnic disparities in breast cancer in the US: towards a more comprehensive model. Health Place 15(3):855–864CrossRefPubMedPubMedCentral
39.
Martin N, Wingfield J (2012) USPSTF screening recommendations for breast cancer: the potential impact on the African American community. J Health Care Poor Underserved 23(2 Suppl):91–97CrossRefPubMed
40.
Kelaher M, Stellman JM (2000) The impact of medicare funding on the use of mammography among older women: implications for improving access to screening. Prev Med 31(6):658–664CrossRefPubMed
41.
Coleman EA, O’Sullivan P (2001) Racial differences in breast cancer screening among women from 65 to 74 years of age: trends from 1987–1993 and barriers to screening. J Women Aging 13(3):23–39CrossRefPubMed
42.
Fincher C, Williams JE, MacLean V, Allison JJ, Kiefe CI, Canto J (2004) Racial disparities in coronary heart disease: a sociological view of the medical literature on physician bias. Ethn Dis 14(3):360–371PubMed
43.
Tait RC, Chibnall JT (2014) Racial/ethnic disparities in the assessment and treatment of pain: psychosocial perspectives. Am Psychol 69(2):131–141CrossRefPubMed
44.
Penner LA, Blair IV, Albrecht TL, Dovidio JF (2014) Reducing racial health care disparities: a social psychological analysis. Policy Insights Behav Brain Sci 1(1):204–212CrossRefPubMedPubMedCentral
45.
Squiers LB, Holden DJ, Dolina SE, Kim AE, Bann CM, Renaud JM (2011) The public’s response to the U.S. Preventive Services Task Force’s 2009 recommendations on mammography screening. Am J Prev Med 40(5):497–504CrossRefPubMed
46.
Davidson AS, Liao X, Magee BD (2011) Attitudes of women in their forties toward the 2009 USPSTF mammogram guidelines: a randomized trial on the effects of media exposure. Am J Obstet Gynecol 205(1):30e1–30e7CrossRef
47.
48.
Allen JD, Bluethmann SM, Sheets M, Opdyke KM, Gates-Ferris K, Hurlbert M et al (2013) Women’s responses to changes in U.S. Preventive Task Force’s mammography screening guidelines: results of focus groups with ethnically diverse women. BMC Public Health 13:1169CrossRefPubMedPubMedCentral
49.
Bao Y, Fox SA, Escarce JJ (2007) Socioeconomic and racial/ethnic differences in the discussion of cancer screening: “between-” versus “within-” physician differences. Health Serv Res 42(3 Pt 1):950–970CrossRefPubMedPubMedCentral
50.
Smith P, Hum S, Kakzanov V, Del Giudice ME, Heisey R (2012) Physicians’ attitudes and behaviour toward screening mammography in women 40 to 49 years of age. Can Fam Physician 58(9):e508–e513PubMedPubMedCentral
51.
Gunn CM, Soley-Bori M, Battaglia TA, Cabral H, Kazis L (2015) Shared decision making and the use of screening mammography in women younger than 50 years of age. J Health Commun 20(9):1060–1066CrossRefPubMed
52.
Dominick KL, Skinner CS, Bastian LA, Bosworth HB, Strigo TS, Rimer BK (2003) Provider characteristics and mammography recommendation among women in their 40s and 50s. J Womens Health (Larchmt) 12(1):61–71CrossRef
53.
Molina Y, Hohl SD, Ko LK, Rodriguez EA, Thompson B, Beresford SA (2014) Understanding the patient-provider communication needs and experiences of Latina and non-Latina White women following an abnormal mammogram. J Cancer Educ 29(4):781–789CrossRefPubMedPubMedCentral
54.
Schouten BC, Meeuwesen L (2006) Cultural differences in medical communication: a review of the literature. Patient Educ Couns 64(1–3):21–34CrossRefPubMed
55.
Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P et al (2012) Shared decision making: a model for clinical practice. J Gen Intern Med 27(10):1361–1367CrossRefPubMedPubMedCentral
56.
Hawley ST, Fagerlin A, Janz NK, Katz SJ (2008) Racial/ethnic disparities in knowledge about risks and benefits of breast cancer treatment: does it matter where you go? Health Serv Res 43(4):1366–1387CrossRefPubMedPubMedCentral
57.
58.
Nelson HD, Weerasinghe R, Wang L, Grunkemeier G (2015) Mammography screening in a large health system following the U.S. Preventive Services Task Force recommendations and the affordable care act. PLoS One 10(6):e0131903CrossRefPubMedPubMedCentral
59.
Artiga S, Damico A, Garfield R (2015) The impact of the coverage gap for adults in states not expanding Medicaid by race and ethnicity. Kaiser Family Foundation, Menlo Park
60.
Tavernise S, Gebeloff R (2013) Millions of poor are left uncovered by health law. The New York Times
61.
Sabik LM, Tarazi WW, Bradley CJ (2015) State Medicaid expansion decisions and disparities in women’s cancer screening. Am J Prev Med 48(1):98–103CrossRefPubMed
62.
Rauscher GH, Johnson TP, Cho YI, Walk JA (2008) Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17(4):748–757CrossRefPubMed
63.
Cronin KA, Miglioretti DL, Krapcho M, Yu B, Geller BM, Carney PA et al (2009) Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev 18(6):1699–1705CrossRefPubMedPubMedCentral
64.
Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG et al (2009) Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338:b2393CrossRefPubMedPubMedCentral
65.
Jena AB, Huang J, Fireman B, Fung V, Gazelle S, Landrum MB et al (2016) Screening mammography for free: impact of eliminating cost sharing on cancer screening rates. Health Serv Res. doi:10.​1111/​1475-6773.​12486
Metadata
Title
Receipt of mammography recommendations among White and non-White women before and after the 2009 United States Preventive Services Task Force recommendation change
Authors
Felisa A. Gonzales
Stephen H. Taplin
Mandi Yu
Nancy Breen
Kathy A. Cronin
Publication date
01-08-2016
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 8/2016
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-016-0775-9

Other articles of this Issue 8/2016

Cancer Causes & Control 8/2016 Go to the issue

Short Communication

Framing research for state policymakers who place a priority on cancer

Original Paper

Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN)

Original paper

Genetic variants in the mTOR pathway and interaction with body size and weight gain on breast cancer risk in African-American and European American women

Original paper

Inequalities in cancer incidence and mortality across medium to highly developed countries in the twenty-first century

Brief report

Vascular morphology differentiates prostate cancer mortality risk among men with higher Gleason grade

Original paper

Inflammatory potential of diet and risk of laryngeal cancer in a case–control study from Italy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits